Key result
Catheter ablation for atrial fibrillation significantly improved Montreal Cognitive Assessment scores at 1 year (24.9 to 26.4, P<0.001), unlike medical therapy (25.4 to 24.8, P=0.012).
Why the study?
Although AF carries a risk of cognitive dysfunction, it was unclear whether catheter ablation improves or worsens cognitive function.
Does radiofrequency catheter ablation improve cognitive function in patients with atrial fibrillation compared to medical therapy?
Case-Control (n=358)
Does radiofrequency catheter ablation improve cognitive function in patients with atrial fibrillation compared to medical therapy?
Catheter ablation for atrial fibrillation is associated with improved cognitive function at 1 year compared to medical therapy, particularly in patients with baseline cognitive impairment.
AF ablation was associated with MoCA gains; leaves open whether ablation causally preserves cognition versus medical therapy.
BACKGROUND: Although atrial fibrillation (AF) has a risk of cognitive dysfunction, it is not clear whether AF catheter ablation improves or worsens cognitive function. This prospective case-control study sought to assess the 1-year serial changes in the cognitive function with or without AF catheter ablation. METHODS: We evaluated the Montreal Cognitive Assessment score in 308 patients (71.4% male, 60.6±9.1 years of age, 34.1% persistent AF) who underwent AF ablation (ablation group) and 50 AF patients on medical therapy who met the same indication for AF ablation (control group), at baseline and 3 and 12 months after enrollment. Cognitive impairment was defined as a published cutoff score of <23 points. To exclude any learning effects, we used the practice-adjusted reliable change index for assessing the cognitive changes. RESULTS: Preablation cognitive impairment was detected in 18.5% (57/308). The Montreal Cognitive Assessment score significantly improved 1 year after radiofrequency catheter ablation in both overall ablation group (24.9±2.9-26.4±2.5; P<0.001) and the propensity-matched ablation group (25.4±2.4-26.5±2.3; P<0.001), but not in the control group (25.4±2.5-24.8±2.5; P=0.012). Preablation cognitive impairment (odds ratio, 13.70; 95% CI, 4.83-38.87; P<0.001) was independently associated with an improvement in the 1-year post-ablation cognitive function. In the reliable change index analyses, 94.7% of propensity-matched ablation group showed an improved/stable cognitive function at the 1-year follow-up. CONCLUSIONS: Catheter ablation of AF, at least, does not deteriorate the cognitive function, but rather improves the performance on 1-year follow-up neurocognitive tests, especially in patients with a preablation cognitive impairment.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2019) conducted a case-control in Atrial Fibrillation (n=358). Catheter ablation vs. Medical therapy was evaluated on Montreal Cognitive Assessment score at 1 year (p=<0.001). Catheter ablation for atrial fibrillation significantly improved Montreal Cognitive Assessment scores at 1 year (24.9 to 26.4, P<0.001), unlike medical therapy (25.4 to 24.8, P=0.012).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: